Security key
171757206
Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX)
CUSIP: 171757206
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,873,669
- Total 13F value
- $183,637,032
- Share change
- +3,565,221
- SEC-reported price per share
- $26.88
- Number of holders
- 40
- Value change
- +$100,865,295
- Number of buys
- 30
- Number of sells
- 7
- Shares outstanding
- 32,142,857
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
40
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of CDTX - Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
40
Shares
6,873,669
Rows available
40
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
27
Q4 2024 holders
40
Holder diff
13
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|